Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bob Olsson

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 11, 2011
Postnatal essential fatty acid deficiency in mice affects lipoproteins, hepatic lipids, fatty acids and mRNA expressionVilborg Palsdottir, Bob Olsson, Jan Borén, et al.
Molecular Medicine Reports|May 18, 2011
Prenatal essential fatty acid deficiency in mice results in long-term gender-specific effects on body weight and glucose metabolismVilborg Palsdottir, Anna Wickman, Birgitta Strandvik, et al.
Behavioral Neuroscience|February 23, 2012
Long-term effects of perinatal essential fatty acid deficiency on anxiety-related behavior in miceVilborg Palsdottir, Jan-Eric Månsson, Maria Blomqvist, et al.
Thrombosis and Haemostasis|January 5, 2005
Disturbed apoptosis of T-cells in patients with active idiopathic thrombocytopenic purpuraBob Olsson, Per-Ola Andersson, Stefan Jacobsson, et al.
Plos One|August 23, 2013
No evidence for a role of adipose tissue-derived serum amyloid a in the development of insulin resistance or obesity-related inflammation in hSAA1(+/-) transgenic miceSofie Ahlin, Maja Olsson, Bob Olsson, et al.
Haematologica|May 30, 2008
Increased cortical bone mineralization in imatinib treated patients with chronic myelogenous leukemiaSofia Jönsson, Bob Olsson, Claes Ohlsson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 13, 2013
The glial marker YKL-40 is decreased in synucleinopathiesBob Olsson, Radu Constantinescu, Björn Holmberg, et al.
Journal of Neuroimmunology|March 4, 2014
CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatmentClas Malmeström, Markus Axelsson, Jan Lycke, et al.
Thrombosis and Haemostasis|February 5, 2016
Normalised immune expression in remission of paediatric ITPMargareta Jernås, Frida Strömberg Célind, Intawat Nookaew, et al.
Journal of Bone and Mineral Metabolism|October 14, 2011
Imatinib inhibits proliferation of human mesenchymal stem cells and promotes early but not late osteoblast differentiation in vitroSofia Jönsson, Henrik Hjorth-Hansen, Bob Olsson, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 11, 2011
Postnatal essential fatty acid deficiency in mice affects lipoproteins, hepatic lipids, fatty acids and mRNA expressionVilborg Palsdottir, Bob Olsson, Jan Borén, et al.
Molecular Medicine Reports|May 18, 2011
Prenatal essential fatty acid deficiency in mice results in long-term gender-specific effects on body weight and glucose metabolismVilborg Palsdottir, Anna Wickman, Birgitta Strandvik, et al.
Behavioral Neuroscience|February 23, 2012
Long-term effects of perinatal essential fatty acid deficiency on anxiety-related behavior in miceVilborg Palsdottir, Jan-Eric Månsson, Maria Blomqvist, et al.
Thrombosis and Haemostasis|January 5, 2005
Disturbed apoptosis of T-cells in patients with active idiopathic thrombocytopenic purpuraBob Olsson, Per-Ola Andersson, Stefan Jacobsson, et al.
Plos One|August 23, 2013
No evidence for a role of adipose tissue-derived serum amyloid a in the development of insulin resistance or obesity-related inflammation in hSAA1(+/-) transgenic miceSofie Ahlin, Maja Olsson, Bob Olsson, et al.
Haematologica|May 30, 2008
Increased cortical bone mineralization in imatinib treated patients with chronic myelogenous leukemiaSofia Jönsson, Bob Olsson, Claes Ohlsson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 13, 2013
The glial marker YKL-40 is decreased in synucleinopathiesBob Olsson, Radu Constantinescu, Björn Holmberg, et al.
Journal of Neuroimmunology|March 4, 2014
CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatmentClas Malmeström, Markus Axelsson, Jan Lycke, et al.
Thrombosis and Haemostasis|February 5, 2016
Normalised immune expression in remission of paediatric ITPMargareta Jernås, Frida Strömberg Célind, Intawat Nookaew, et al.
Journal of Bone and Mineral Metabolism|October 14, 2011
Imatinib inhibits proliferation of human mesenchymal stem cells and promotes early but not late osteoblast differentiation in vitroSofia Jönsson, Henrik Hjorth-Hansen, Bob Olsson, et al.
Pageof 8